Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 2028936, 16 pages
https://doi.org/10.1155/2018/2028936
Research Article

Simvastatin Treatment Upregulates HO-1 in Patients with Abdominal Aortic Aneurysm but Independently of Nrf2

1Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland
2Department of Surgery, Division of Vascular Surgery, Medical University of Vienna, Vienna, Austria

Correspondence should be addressed to Aleksandra Piechota-Polanczyk; moc.liamg@ardnaskela.atohceip

Received 23 August 2017; Revised 8 January 2018; Accepted 16 January 2018; Published 20 March 2018

Academic Editor: Nageswara Madamanchi

Copyright © 2018 Aleksandra Piechota-Polanczyk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Yajima, M. Masuda, M. Miyazaki, N. Nakajima, S. Chien, and J. Y. Shyy, “Oxidative stress is involved in the development of experimental abdominal aortic aneurysm: a study of the transcription profile with complementary DNA microarray,” Journal of Vascular Surgery, vol. 36, no. 2, pp. 379–385, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. C. Ho, M. L. Wu, P. Y. Gung, C. H. Chen, C. C. Kuo, and S. F. Yet, “Heme oxygenase-1 deficiency exacerbates angiotensin II-induced aortic aneurysm in mice,” Oncotarget, vol. 7, no. 42, pp. 67760–67776, 2016. View at Publisher · View at Google Scholar
  3. J. Azuma, R. J. Wong, T. Morisawa et al., “Heme oxygenase-1 expression affects murine abdominal aortic aneurysm progression,” PLoS One, vol. 11, no. 2, article e0149288, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. H. J. Duckers, M. Boehm, A. L. True et al., “Heme oxygenase-1 protects against vascular constriction and proliferation,” Nature Medicine, vol. 7, no. 6, pp. 693–698, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. C. T. Wagner, W. Durante, N. Christodoulides, J. D. Hellums, and A. I. Schafer, “Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells,” The Journal of Clinical Investigation, vol. 100, no. 3, pp. 589–596, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Durante, “Targeting heme oxygenase-1 in vascular disease,” Current Drug Targets, vol. 11, no. 12, pp. 1504–1516, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. L. Ferrandiz and I. Devesa, “Inducers of heme oxygenase-1,” Current Pharmaceutical Design, vol. 14, no. 5, pp. 473–486, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Jez, M. Ciesla, J. Stepniewski et al., “Valproic acid downregulates heme oxygenase-1 independently of Nrf2 by increasing ubiquitination and proteasomal degradation,” Biochemical and Biophysical Research Communications, vol. 485, no. 1, pp. 160–166, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Loboda, M. Damulewicz, E. Pyza, A. Jozkowicz, and J. Dulak, “Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism,” Cellular and molecular life sciences, vol. 73, no. 17, pp. 3221–3247, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Dhakshinamoorthy, A. K. Jain, D. A. Bloom, and A. K. Jaiswal, “Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants,” The Journal of Biological Chemistry, vol. 280, no. 17, pp. 16891–16900, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. S. H. Choi, S. Park, C. J. Oh, J. Leem, K. G. Park, and I. K. Lee, “Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation,” Vascular Pharmacology, vol. 73, no. 11, pp. 11–19, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Liu, B. Wang, T. Wang et al., “Ursodeoxycholic acid attenuates acute aortic dissection formation in angiotensin II-infused apolipoprotein E-deficient mice associated with reduced ROS and increased Nrf2 levels,” Cellular Physiology and Biochemistry, vol. 38, no. 4, pp. 1391–1405, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Chigusa, K. Kawasaki, E. Kondoh et al., “Simvastatin inhibits oxidative stress via the activation of nuclear factor erythroid 2-related factor 2 signaling in trophoblast cells,” The Journal of Obstetrics and Gynaecology Research, vol. 42, no. 1, pp. 36–43, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. M. Kim, H. O. Pae, J. E. Park et al., “Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities,” Antioxidants & Redox Signaling, vol. 14, no. 1, pp. 137–167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Schachter, “Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update,” Fundamental & Clinical Pharmacology, vol. 19, no. 1, pp. 117–125, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Scott and M. D. Grundy, “Consensus statement: role of therapy with “statins” in patients with hypertriglyceridemia,” The American Journal of Cardiology, vol. 81, no. 4, pp. 1B–6B, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Piechota-Polanczyk and A. Jozkowicz, “The role of statins in the activation of heme oxygenase-1 in cardiovascular diseases,” Current Drug Targets, vol. 18, no. 6, pp. 674–686, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Piechota-Polanczyk, S. Demyanets, M. Mittlboeck et al., “The influence of simvastatin on NGAL, matrix metalloproteinases and their tissue inhibitors in human intraluminal thrombus and abdominal aortic aneurysm tissue,” European Journal of Vascular and Endovascular Surgery, vol. 49, no. 5, pp. 549–555, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Piechota-Polanczyk, S. Demyanets, O. Nykonenko et al., “Decreased tissue levels of cyclophilin A, a cyclosporine A target and phospho-ERK1/2 in simvastatin patients with abdominal aortic aneurysm,” European Journal of Vascular and Endovascular Surgery, vol. 45, no. 6, pp. 682–688, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Piechota-Polanczyk, A. Goraca, S. Demyanets et al., “Simvastatin decreases free radicals formation in the human abdominal aortic aneurysm wall via NF-κB,” European Journal of Vascular and Endovascular Surgery, vol. 44, no. 2, pp. 133–137, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Eilenberg, S. Stojkovic, A. Kaider et al., “NGAL and MMP-9/NGAL as biomarkers of plaque vulnerability and targets of statins in patients with carotid atherosclerosis,” Clinical Chemistry and Laboratory Medicine, vol. 56, no. 1, pp. 147–156, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. K. R. Brunt, K. K. Fenrich, G. Kiani et al., “Protection of human vascular smooth muscle cells from H2O2-induced apoptosis through functional codependence between HO-1 and AKT,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 9, pp. 2027–2034, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. I. G. Habeos, P. G. Ziros, D. Chartoumpekis, A. Psyrogiannis, V. Kyriazopoulou, and A. G. Papavassiliou, “Simvastatin activates Keap1/Nrf2 signaling in rat liver,” Journal of Molecular Medicine, vol. 86, no. 11, pp. 1279–1285, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. H. Yeh, C. T. Kuo, G. J. Chang et al., “Rosuvastatin suppresses atrial tachycardia-induced cellular remodeling via Akt/Nrf2/heme oxygenase-1 pathway,” Journal of Molecular and Cellular Cardiology, vol. 82, no. 24, pp. 84–92, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Pantan, J. Tocharus, A. Suksamrarn, and C. Tocharus, “Synergistic effect of atorvastatin and cyanidin-3-glucoside on angiotensin II-induced inflammation in vascular smooth muscle cells,” Experimental Cell Research, vol. 342, no. 2, pp. 104–112, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Dong, S. Vuletic, and J. J. Albers, “Differential effects of simvastatin and pravastatin on expression of Alzheimer’s disease-related genes in human astrocytes and neuronal cells,” Journal of Lipid Research, vol. 50, no. 10, pp. 2095–2102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Wiktorowska-Owczarek, “The effect of valdecoxib on the production of growth factors evoked by hypoxia and bacterial lipopolysaccharide in HMEC-1 cells,” Advances in Clinical and Experimental Medicine, vol. 22, no. 28, pp. 795–800, 2013. View at Google Scholar
  28. A. Loboda, E. Rojczyk-Golebiewska, B. Bednarczyk-Cwynar, Z. Lucjusz, A. Jozkowicz, and J. Dulak, “Targeting Nrf2-mediated gene transcription by triterpenoids and their derivatives,” Biomolecules & Therapeutics, vol. 20, no. 6, pp. 499–505, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Giustarini, I. Dalle-Donne, A. Milzani, P. Fanti, and R. Rossi, “Analysis of GSH and GSSG after derivatization with N-ethylmaleimide,” Nature Protocols, vol. 8, no. 9, pp. 1660–1669, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Was, M. Sokolowska, A. Sierpniowska et al., “Effects of heme oxygenase-1 on induction and development of chemically induced squamous cell carcinoma in mice,” Free Radical Biology & Medicine, vol. 51, no. 9, pp. 1717–1726, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Kansanen, S. M. Kuosmanen, H. Leinonen, and A. L. Levonen, “The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer,” Redox Biology, vol. 1, no. 1, pp. 45–49, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Lavrovsky, M. L. Schwartzman, R. D. Levere, A. Kappas, and N. G. Abraham, “Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 13, pp. 5987–5991, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. T. S. Lee, C. C. Chang, Y. Zhu, and J. Y. Shyy, “Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection,” Circulation, vol. 110, no. 10, pp. 1296–1302, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. K. J. Kim, K. S. Kim, N. R. Kim, and H. S. Chin, “Effects of simvastatin on the expression of heme oxygenase-1 in human RPE cells,” Investigative Ophthalmology & Visual Science, vol. 53, no. 10, pp. 6456–6464, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. J. E. Keskitalo, M. K. Pasanen, P. J. Neuvonen, and M. Niemi, “Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin,” Pharmacogenomics, vol. 10, no. 10, pp. 1617–1624, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Bjorkhem-Bergman, J. D. Lindh, and P. Bergman, “What is a relevant statin concentration in cell experiments claiming pleiotropic effects?” British Journal of Clinical Pharmacology, vol. 72, no. 1, pp. 164-165, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Lennernas and G. Fager, “Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences,” Clinical Pharmacokinetics, vol. 32, no. 5, pp. 403–425, 1997. View at Publisher · View at Google Scholar
  38. H. Dreger, K. Westphal, N. Wilck et al., “Protection of vascular cells from oxidative stress by proteasome inhibition depends on Nrf2,” Cardiovascular Research, vol. 85, no. 2, pp. 395–403, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Luo, S. Lu, X. Dong, L. Xu, G. Sun, and X. Sun, “Dihydromyricetin protects human umbilical vein endothelial cells from injury through ERK and Akt mediated Nrf2/HO-1 signaling pathway,” Apoptosis, vol. 22, no. 8, pp. 1013–1024, 2017. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Ishizaka, H. de Leon, J. B. Laursen et al., “Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta,” Circulation, vol. 96, no. 6, pp. 1923–1929, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Ashino, M. Yamamoto, and S. Numazawa, “Nrf2/Keap1 system regulates vascular smooth muscle cell apoptosis for vascular homeostasis: role in neointimal formation after vascular injury,” Scientific Reports, vol. 6, no. 1, article 26291, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Taha, K. Skrzypek, I. Guevara et al., “Role of heme oxygenase-1 in human endothelial cells: lesson from the promoter allelic variants,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 8, pp. 1634–1641, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. X. Jin, Z. Xu, R. Fan et al., “HO-1 alleviates cholesterol-induced oxidative stress through activation of Nrf2/ERK and inhibition of PI3K/AKT pathways in endothelial cells,” Molecular Medicine Reports, vol. 16, no. 3, pp. 3519–3527, 2017. View at Publisher · View at Google Scholar · View at Scopus
  44. A. L. Levonen, M. Inkala, T. Heikura et al., “Nrf2 gene transfer induces antioxidant enzymes and suppresses smooth muscle cell growth in vitro and reduces oxidative stress in rabbit aorta in vivo,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 4, pp. 741–747, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Loboda, A. Jazwa, A. Jozkowicz et al., “Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells,” Atherosclerosis, vol. 187, no. 1, pp. 26–30, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Ikawa, T. Nishioka, Z. Yu et al., “Involvement of neutrophil recruitment and protease-activated receptor 2 activation in the induction of IL-18 in mice,” Journal of Leukocyte Biology, vol. 78, no. 5, pp. 1118–1126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Grochot-Przeczek, J. Kotlinowski, M. Kozakowska et al., “Heme oxygenase-1 is required for angiogenic function of bone marrow-derived progenitor cells: role in therapeutic revascularization,” Antioxidants & Redox Signaling, vol. 20, no. 11, pp. 1677–1692, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Kozakowska, J. Kotlinowski, A. Grochot-Przeczek et al., “Myoblast-conditioned media improve regeneration and revascularization of ischemic muscles in diabetic mice,” Stem Cell Research & Therapy, vol. 6, no. 1, p. 61, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Kozakowska, M. Ciesla, A. Stefanska et al., “Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs,” Antioxidants & Redox Signaling, vol. 16, no. 2, pp. 113–127, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Jozkowicz, I. Huk, A. Nigisch, G. Weigel, F. Weidinger, and J. Dulak, “Effect of prostaglandin-J2 on VEGF synthesis depends on the induction of heme oxygenase-1,” Antioxidants & Redox Signaling, vol. 4, no. 4, pp. 577–585, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Jazwa, A. Loboda, S. Golda et al., “Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratinocytes,” Free Radical Biology & Medicine, vol. 40, no. 7, pp. 1250–1263, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Loboda, A. Stachurska, U. Florczyk et al., “HIF-1 induction attenuates Nrf2-dependent IL-8 expression in human endothelial cells,” Antioxidants & Redox Signaling, vol. 11, no. 7, pp. 1501–1517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Dulak, A. Jozkowicz, R. Foresti et al., “Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells,” Antioxidants & Redox Signaling, vol. 4, no. 2, pp. 229–240, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Jozkowicz and J. Dulak, “Effects of protoporphyrins on production of nitric oxide and expression of vascular endothelial growth factor in vascular smooth muscle cells and macrophages,” Acta Biochimica Polonica, vol. 50, no. 54, pp. 69–79, 2003. View at Google Scholar